| Literature DB >> 18369452 |
Tiffany Renee Oliver1, Eleanor Feingold, Kai Yu, Vivian Cheung, Stuart Tinker, Maneesha Yadav-Shah, Nirupama Masse, Stephanie L Sherman.
Abstract
Nondisjunction of chromosome 21 is the leading cause of Down syndrome. Two risk factors for maternal nondisjunction of chromosome 21 are increased maternal age and altered recombination. In order to provide further insight on mechanisms underlying nondisjunction, we examined the association between these two well established risk factors for chromosome 21 nondisjunction. In our approach, short tandem repeat markers along chromosome 21 were genotyped in DNA collected from individuals with free trisomy 21 and their parents. This information was used to determine the origin of the nondisjunction error and the maternal recombination profile. We analyzed 615 maternal meiosis I and 253 maternal meiosis II cases stratified by maternal age. The examination of meiosis II errors, the first of its type, suggests that the presence of a single exchange within the pericentromeric region of 21q interacts with maternal age-related risk factors. This observation could be explained in two general ways: 1) a pericentromeric exchange initiates or exacerbates the susceptibility to maternal age risk factors or 2) a pericentromeric exchange protects the bivalent against age-related risk factors allowing proper segregation of homologues at meiosis I, but not segregation of sisters at meiosis II. In contrast, analysis of maternal meiosis I errors indicates that a single telomeric exchange imposes the same risk for nondisjunction, irrespective of the age of the oocyte. Our results emphasize the fact that human nondisjunction is a multifactorial trait that must be dissected into its component parts to identify specific associated risk factors.Entities:
Mesh:
Year: 2008 PMID: 18369452 PMCID: PMC2265487 DOI: 10.1371/journal.pgen.1000033
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Frequency Distribution of Observed Recombinants and Inferred Exchanges for each Meiotic Outcome Group Stratified by Maternal Age Group.
| Meiotic outcome group | Maternal age group | Number of observed events | Frequency of observed number recombinants | Frequency of the number inferred exchanges | ||||
| 0 | 1 | ≥2 | 0 | 1 | ≥2 | |||
|
| ||||||||
| Young (<29 yrs) | 175 | 0.70 | 0.20 | 0.10 | 0.47 | 0.32 | 0.21 | |
| Mid (29–34 yrs) | 197 | 0.56 | 0.35 | 0.10 | 0.18 | 0.64 | 0.19 | |
| Old (>34 yrs) | 243 | 0.64 | 0.27 | 0.09 | 0.27 | 0.49 | 0.24 | |
|
| ||||||||
| Young (<29 yrs) | 58 | – | 0.66 | 0.34 | – | 0.22 | 0.78 | |
| Mid (29–34 yrs) | 69 | – | 0.78 | 0.22 | – | 0.51 | 0.49 | |
| Old (>34 yrs) | 126 | – | 0.81 | 0.19 | – | 0.57 | 0.44 | |
|
| ||||||||
| All Ages | 152 | 0.52 | 0.39 | 0.09 | 0.20 | 0.50 | 0.30 | |
Spatial Distribution of Inferred Single Exchanges for Each Meiotic Outcome Group Stratified by Maternal Age Group.
| Meiotic outcome group | Maternal age group | Interval location of inferred single exchange (centromere to telomere) | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | Average interval | ||
|
| ||||||||
| Young (<29 yrs) | 0.08 | 0.09 | 0.00 | 0.05 | 0.37 | 0.41 | 4.77 | |
| Mid (29–34 yrs) | 0.02 | 0.06 | 0.08 | 0.23 | 0.46 | 0.16 | 4.53 | |
| Old (>34 yrs) | 0.05 | 0.08 | 0.09 | 0.29 | 0.40 | 0.09 | 4.18 | |
|
| ||||||||
| Young (<29 yrs) | 0.00 | 0.10 | 0.38 | 0.27 | 0.23 | 0.03 | 3.75 | |
| Mid (29–34 yrs) | 0.35 | 0.21 | 0.11 | 0.16 | 0.17 | 0.00 | 2.59 | |
| Old (>34 yrs) | 0.40 | 0.30 | 0.14 | 0.08 | 0.07 | 0.02 | 2.25 | |
|
| ||||||||
| All Ages | 0.02 | 0.15 | 0.21 | 0.28 | 0.28 | 0.07 | 3.87 | |
Figure 1Comparison of Spatial Distributions of Single Exchanges for Meiotic Outcome Groups by Maternal Age.
This figure summarizes the data from Table 2. Each color denotes the proportion of single exchanges that are inferred to occur in that specific interval. Proportions were inferred using tetrad analysis and were based on the recombination profiles of meiotic events within age groups and within meiotic outcome group.
Figure 2Rate of Trisomy 21 by Maternal age and by Type of Error.
Within each maternal age group, the bars indicate the proportion of that rate that is explained by each type of nondisjunction error. See Materials and Methods for the calculation of the proportions.
Figure 3Markers used to Define the Origin of the Meiotic Error and Determine the Recombination Profile.
Approximately 21 markers were genotyped on each individual in the study. This information was used first to determine the origin (maternal or paternal and meiosis I or II) of the nondisjoining error. Only cases in which the error was maternal in origin were included in this study. Once the origin of the error was defined, this genotyping information was used to determine the number and location of recombination (i.e., recombination profile). 21q was divided into six intervals of approximately equal physical length. Each observed recombinant was defined as being located in one of six defined intervals.